Cataract News and Research

Latest Cataract News and Research

NHS surgery waiting times and time of discharge under scrutiny

The NHS medical director Prof Sir Bruce Keogh, has written to Strategic Health Authorities saying it is unacceptable to send people home when they may have no family support. Figures show that 100 NHS trusts sent 239,233 patients home between 23:00 and 06:00 in 2011. The Times reported that some 3.5% of all hospital discharges took place between those hours and this rate had steadily held for the past five years. The Times had contacted 170 NHS trusts in England but only 100 responded. The rates of those discharged varied widely between different hospitals.

19 Apr 2012

Asthma treatment still inadequate in Australia

Writing in the latest edition of Australian Prescriber, Associate Professor Helen Reddel, research leader at the Woolcock Institute of Medical Research says many people are prescribed higher doses than necessary. Most people do not use their inhalers correctly, leading to poor clinical outcomes and wasted medicines.

15 Apr 2012

OptiMedica's Catalys Precision Laser System receives CE mark approval

Global ophthalmic company OptiMedica Corp. has announced that its Catalys Precision Laser System has been CE mark approved for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.

12 Apr 2012

Omeros initiates enrollment in second Phase 3 trial of OMS302

Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.

10 Apr 2012

Changes in corneal thickness occur in patients at early stages of FECD

A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs' Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can eventually lead to the need for corneal transplantation.

10 Apr 2012

Monitoring necessary for early intervention in Fuchs' Endothelial Corneal Dystrophy patients

10 Apr 2012

Oral fluoroquinolones increase risk of retinal detachment

In an analysis of a cohort that included nearly one million patients who had visited an ophthalmologist, patients who were taking oral fluoroquinolones had a higher risk of developing a retinal detachment, a serious eye condition, compared with nonusers, although the absolute risk was small, according to a study in the April 4 issue of JAMA.

4 Apr 2012

LensAR closes $24 million private financing

LensAR Inc., a developer of the next generation of laser systems for cataract surgery, announced the closing of a $24 million private financing which included investments from Aisling Capital and Florida Growth Fund (FGF).

12 Mar 2012

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that the FDA required AstraZeneca to include in the labeling for SEROQUEL (quetiapine fumarate) tablets and SEROQUEL XR (quetiapine fumarate) extended-release tablets.

12 Mar 2012

Australian TGA approves Bayer's EYLEA for treatment of wet AMD

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has received approval from the Australian Therapeutic Goods Administration (TGA) for EYLEA (aflibercept) Injection for the treatment of patients with neovascular (wet) age-related macular degeneration (wet AMD) at a recommended dose of 2 milligrams (mg) via intravitreal injection per month for three consecutive months, followed by 2 milligrams via intravitreal injection every two months.

8 Mar 2012

Ivantis initiates enrollment in Hydrus Microstent study for open angle glaucoma

Ivantis announced the enrollment of the first patient in the Hydrus IV study today. The Hydrus Microstent is the world's first intracanalicular scaffold for treatment of primary open angle glaucoma, a disease that afflicts over 70 million people worldwide and approximately 3 million people in the United States.

6 Mar 2012

Survey: Americans spend more for health care than people in other countries

The report from the International Federation of Health Plans found that Americans pay more for physician time, for scans, surgery and drugs than people in other countries. Also in the news, other reports from the health care marketplace explore the lack of insurance coverage for reproductive-age women and the growth in the number of companies that are offering incentives to their employees to better manage their health.

5 Mar 2012

OptiMedica launches Catalys Precision Laser System in the US

Global ophthalmic company OptiMedica Corp. has announced the launch of its Catalys Precision Laser System in the United States, with the first patient cases performed by Drs. Mike and Paul Mann at the Mann Eye Institute in Houston.

27 Feb 2012

MSU students analyze bones for clues into Nubians' diets, health histories and lifestyles

In a narrow, modest laboratory in Michigan State University's Giltner Hall, students pore over African skeletons from the Middle Ages in an effort to make the bones speak. Little is known about these Nubians, meaning the information collected by graduate and undergraduate students in MSU's Forensic Anthropology and Bioarchaeology Program will help shed light on this unexplored culture.

24 Feb 2012

First comprehensive framework to close the gap on Indigenous eye health for Australians

Presently Indigenous Australians suffer six times the blindness of mainstream Australians and 94 percent of vision loss in Indigenous Australians is unnecessary, preventable or treatable.

24 Feb 2012

Wolters Kluwer, APAO launch Asia-Pacific Journal of Ophthalmology

Wolters Kluwer Health and the Asia-Pacific Academy of Ophthalmology (APAO) are pleased to announce the launch of the Asia-Pacific Journal of Ophthalmology.

24 Feb 2012

Viewpoints: Health law's consumer safeguards; Shredding Medicare's safety net; Georgia's trauma crisis

Requiring the makers of drugs and medical devices to disclose most payments and gifts to physicians will protect patients and reduce medical costs. ... [the federal health law] requires the makers of drugs and medical devices to disclose most payments and gifts to physicians (1/27).

30 Jan 2012

Hawaii surgeons successfully implant FDA-approved eye telescope for AMD

A team of surgeons from Hawaii, Dr. Michael Bennett of Retina Institute of Hawaii and Dr. Michael McMann of McMann Institute, has successfully implanted the FDA-approved eye telescope, a first in Hawaii, at one of the leading medical centers in Honolulu.

19 Jan 2012

Safety nets in Australia’s Medicare questioned while expert claims $3 billion inappropriate use

In a scathing article for the Medical Journal of Australia published on Monday, GP Dr Tony Webber has described the Medicare scheme as a “monster”. He wrote, “I estimate that $2 billion to $3 billion are spent inappropriately each year.” As former chief of the Professional Services Review - set up to police Medicare - he said he gained insight into how dysfunctional the system had become.

16 Jan 2012

Study finds risk factors associated with exfoliation syndrome

When it comes to whether or not you will develop exfoliation syndrome (ES) -- an eye condition that is a leading cause of secondary open-angle glaucoma and increased risk of cataract as well as cataract surgery complications -- age, gender and where you live does matter.

2 Jan 2012